Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Clinigen Group Plc (CLINC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Clinigen historical data, for real-time data please try another search
925.00 +0.00    +0.00%
01/04 - Real-time Data. Currency in GBP ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 922.00 / 925.50
  • Day's Range: 924.00 - 925.00
Type:  Equity
Market:  United Kingdom
ISIN:  GB00B89J2419 
SEDOL:  B89J241
Clinigen 925.00 +0.00 +0.00%

LON:CLINC Financials

 
This summary provides an overview of the most significant critical numbers from each of the Clinigen financial reports, including theClinigen Group Plc income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the LON:CLINC financials over time via breakdowns of their annual reports.

Clinigen Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was GBP 588 million compared to GBP 523.6 million a year ago. Net loss was GBP 0.1 million compared to net income of GBP 30.3 million a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

CLINC Income Statement & Profits

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Dec 31, 2021 Jun 30, 2021 Dec 31, 2020 Jun 30, 2020
Total Revenue 283.9 523.6 241.9 466.7
Gross Profit 100.4 197.9 96.2 205.1
Operating Income 17.5 60.1 26.5 34.4
Net Income 7.2 30.3 18 13.7

CLINC Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2021 Jun 30, 2021 Dec 31, 2020 Jun 30, 2020
Total Assets 1048.6 1065.6 1021.7 1142
Total Liabilities 593.5 618.6 583.8 696.4
Total Equity 455.1 447 437.9 445.6

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  37.89%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2021 Jun 30, 2021 Dec 31, 2020 Jun 30, 2020
Period Length: 6 Months 0 Months 6 Months 12 Months
Cash From Operating Activities 59.3 45.2 13.7 60.6
Cash From Investing Activities -14 -60.5 -47 -81.4
Cash From Financing Activities -9.7 -38.9 -41.5 77.9
Net Change in Cash 34.6 -60.2 -80.2 59.6
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CLINC Price Commentary

Write your thoughts about Clinigen Group Plc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Yasin Raj
Yasin Raj Apr 19, 2024 12:21
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yasin
Irtza Abbas
Irtza Abbas Mar 23, 2024 18:42
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Irfan Ullah
Irfan Ullah Oct 04, 2023 18:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sasanknor Changmai
Sasanknor Changmai Sep 23, 2023 2:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stewart Cowley
Stewart Cowley Dec 04, 2021 20:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
People have had a go at this stock to “release value” when it has been £8 -£10. On that basis, from here, id the bid is successful, there 40 - 70% upside in the next week or so…
Stewart Cowley
Stewart Cowley Dec 02, 2021 15:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
And here comes ANOTHER bid for Clinigen. The problem is - nobody knows how to value it…
Kefah Mokbel
Kefah Mokbel Sep 17, 2020 15:17
Saved. See Saved Items.
This comment has already been saved in your Saved Items
An ideal target for takeover
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email